Story perspectives

San Francisco Startup Raises $30M for Gene-Editing Research

11/19/2025

Summary

Story summary

Preventive, a San Francisco startup, has raised nearly $30 million to develop embryo gene-editing technology that prevents hereditary diseases.
Co-founder Lucas Harrington says safety must be established before clinical use.
Gene-edited babies are illegal in the United States, the United Kingdom, and most countries, prompting Preventive to pursue United Arab Emirates (UAE) clinical work.
Dr. Richard Land warns about ethical issues and questions who would decide which traits to value.

1 of 1

Story summary

Preventive, a San Francisco startup, has raised nearly $30 million to develop embryo gene-editing technology that prevents hereditary diseases.
Co-founder Lucas Harrington says safety must be established before clinical use.
Gene-edited babies are illegal in the United States, the United Kingdom, and most countries, prompting Preventive to pursue United Arab Emirates (UAE) clinical work.
Dr. Richard Land warns about ethical issues and questions who would decide which traits to value.